BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C AND Treatment
13 results:

  • 1. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer.
    Rodríguez Pérez A; Felip Font E; Chicas-Sett R; Montero-Luis Á; de Paz Arias L; González-Del-Alba A; López-Campos F; López López C; Hernando Requejo O; Conde-Moreno AJ; Arranz Arija JÁ; de Castro Carpeño J
    Clin Transl Oncol; 2023 Apr; 25(4):882-896. PubMed ID: 36525231
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
    Conde-Moreno AJ; González-Del-Alba A; López-Campos F; López López C; Requejo OH; de Castro Carpeño J; Chicas-Sett R; de Paz Arias L; Montero-Luis Á; Pérez AR; Font EF; Arija JÁA
    Clin Transl Oncol; 2023 Apr; 25(4):897-911. PubMed ID: 36525230
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study.
    Kroese TE; Takahashi Y; Lordick F; van Rossum PSN; Ruurda JP; Lagarde SM; van Hillegersberg R; Verhoeven RHA; van Laarhoven HWM
    Eur J Cancer; 2023 Jan; 179():65-75. PubMed ID: 36509000
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
    Gold D; Nicolay L; Avian A; Greimel E; Balic M; Pristauz-Telsnigg G; Tamussino K; Trutnovsky G
    Maturitas; 2023 Jan; 167():1-7. PubMed ID: 36279690
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
    Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
    Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patient and treatment Factors Associated With Improved Local Control and Survival in Oligometastatic Bone Disease: Results From a Large Single-Institution Experience Using Stereotactic Body Radiation Therapy.
    Thomas MC; Chen YH; Fite E; Pangilinan A; Bubelo K; Spektor A; Balboni TA; Huynh MA
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):747-761. PubMed ID: 35840113
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective.
    Piroth MD; Krug D; Feyer P; Baumann R; Combs S; Duma MN; Dunst J; Fastner G; Fietkau R; Guckenberger M; Haase W; Harms W; Hehr T; Sedlmayer F; Souchon R; Strnad V; Budach W
    Strahlenther Onkol; 2022 Jul; 198(7):601-611. PubMed ID: 35527272
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The continuing conundrum in oligometastatic breast carcinoma: A real-world data.
    Selvarajan G; Dhanushkodi M; Radhakrishnan V; Kalaiyarasi JP; Murali CS; Ananthi B; Iyer P; Krishnamurthy A; Velusamy S; Ganesarajah S; Sagar TG
    Breast; 2022 Jun; 63():140-148. PubMed ID: 35395472
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Approach to Oligometastatic cancer in the Elderly Patient.
    Winter IW; Smile TD; Videtic GMM
    Curr Oncol Rep; 2021 Aug; 23(11):122. PubMed ID: 34448967
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Imaging and its Impact on Defining the Oligometastatic State.
    Pirasteh A; Lovrec P; Pedrosa I
    Semin Radiat Oncol; 2021 Jul; 31(3):186-199. PubMed ID: 34090645
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and treatment of cancer imaging group.
    deSouza NM; Liu Y; Chiti A; Oprea-Lager D; Gebhart G; Van Beers BE; Herrmann K; Lecouvet FE
    Eur J Cancer; 2018 Mar; 91():153-163. PubMed ID: 29331524
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Management of liver dominant metastatic breast cancer: surgery, chemotherapy, or hepatic arterial therapy - benefits and limitations.
    Rodes Brown S; Martin RC
    Minerva Chir; 2012 Aug; 67(4):297-308. PubMed ID: 23022754
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy.
    Chan A; Chen C; Chiang J; Tan SH; Ng R
    Support Care Cancer; 2012 Jul; 20(7):1525-32. PubMed ID: 21818641
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.